China Urology Disorders Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the China Urology Disorders Market was valued at USD 1.11 billion in 2025 and is projected to reach USD 1.82 billion by 2032, growing at a CAGR of approximately 7.3% during 2026–2032.
China Urology Disorders Market Highlights
| Report Metric | Details |
| Report Name | China Urology Disorders Market |
| Market Size 2025 | USD 1.11 billion |
| Market Size 2032 | USD 1.82 billion |
| Absolute Growth 2025–2032 | USD 0.71 billion |
| CAGR 2026–2032 | 7.3% |
| Peak Annual Growth | 8.9% in 2029 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Disorder Type, 2025 | Male Urology (44% share) |
| Leading Age Group, 2025 | Elderly (>60) (47% share) |
| Leading Treatment Pathway, 2025 | Medication (35% share) |
| Leading End User, 2025 | Pediatric Hospitals (40% share) |
| Fastest-Growing Disorder Type | Pediatric Urology (8.6% CAGR) |
| Fastest-Growing Age Group | Children (0–16) (9.1% CAGR) |
| Fastest-Growing Treatment Pathway | Monitoring (9.6% CAGR) |
| Growing Sector | Geriatric Urology |
| Key End Users | Pediatric hospitals, long-term care units, healthcare providers, urban hospitals |
China Urology Disorders Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
Below, each year's estimated growth is shown next to the factor that most influenced it.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 7.2 | The market showed strong demand due to a growing elderly population requiring urological care. |
| 2023 | 6.8 | Growth slowed as healthcare providers adjusted to the 'Urology Health Promotion Initiative' and new treatment protocols. |
| 2024 | 5.9 | Continued adjustments in treatment pathways led to further slowing in growth rates. |
| 2025 | 6.9 | Demand increased as healthcare facilities expanded their urology services to meet patient needs. |
| 2026 | 8.6 | Investment in advanced medical technologies is expected to boost growth as facilities upgrade equipment. |
| 2027 | 7.2 | Growth is projected to slow as the market stabilises after rapid expansions in previous years. |
| 2028 | 5.2 | Market growth is expected to slow as the focus shifts to improving patient outcomes and quality of care. |
| 2029 | 8.9 | A surge in demand for pediatric urology services is projected to drive higher growth rates this year. |
| 2030 | 8.5 | Growth is expected to moderate as healthcare providers adapt to evolving treatment standards and protocols. |
| 2031 | 5.9 | The market will experience slower growth due to increased competition among healthcare facilities. |
| 2032 | 7.0 | Demand for geriatric urology services is expected to rise as the elderly population continues to grow. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
China Urology Disorders Market Synopsis
The Urology Disorders market in China encompasses various conditions affecting the urinary system, including kidney stones and prostate disorders. It is primarily addressed through medical interventions such as surgery and medication. The China Urology Disorders Market is growing as the population ages and healthcare facilities improve their urological services. In 2022, urological disorders accounted for 10% of all hospital admissions, highlighting the demand for urological care. The 'Urology Care Improvement Program' launched in 2023 aims to improve treatment standards, further driving market growth.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Aging population increasing the prevalence of urological disorders. | Driver | High | Geriatric Urology |
| Growing number of pediatric hospitals enhancing urological care for children. | Driver | High | Pediatric Urology |
| Rising awareness about urological health among the general public. | Opportunity | High | Male Urology |
| Increasing investment in urological surgical equipment and technologies. | Opportunity | High | Surgery |
| Limited access to specialized urological care in rural areas. | Restraint | Medium | Geriatric Urology |
| High costs associated with advanced urological treatments. | Restraint | Medium | Male Urology |
| Healthcare providers face challenges in adopting new treatment protocols. | Challenge | High | Male Urology |
| Competition among healthcare facilities can lead to service quality variations. | Challenge | Medium | Pediatric Urology |
Evaluation of Drivers in China Urology Disorders Market (2026–2032)
Below mentioned are some major drivers and their influence on market dynamics.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Increasing investment in healthcare infrastructure. | Geriatric Urology | This investment supports facilities' capabilities to provide specialized care for the elderly, with over 200 million adults over 60 years old in China. |
| Rising prevalence of prostate disorders among men aged 65 and older. | Male Urology | This demographic shift drives demand for diagnostic and treatment services, as the average age for diagnosis is 65 years. |
| Expansion of pediatric hospitals equipped to handle urological disorders. | Pediatric Urology | These facilities address the specific needs of children, with over 1,000 pediatric hospitals across China. |
| Growing public awareness campaigns about urological health. | Male Urology | Such campaigns encourage individuals to seek timely medical interventions, improving overall health outcomes. |
| Advancements in medical technologies for urological treatments. | Surgery | New technologies improve surgical outcomes, attracting more patients seeking effective solutions, with over 30,000 surgical units reported. |
The Urology Disorders market in China is growing on the back of increased investment in healthcare infrastructure, which supports facilities' capabilities. The rising prevalence of prostate disorders among men aged 65 and older drives demand for diagnostic and treatment services. Expansion of pediatric hospitals equipped to handle urological disorders addresses the specific needs of children, leading to higher patient volumes. Public awareness campaigns about urological health encourage timely medical interventions, resulting in increased demand for services. Advancements in medical technologies for urological treatments improve surgical outcomes, attracting more patients seeking effective solutions, with over 30,000 surgical units reported in use across China.
Evaluation of Restraints in China Urology Disorders Market
The main factors holding the market back are set out below.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Limited access to specialized urological care in rural areas. | Geriatric Urology | Rural healthcare facilities often lack the necessary resources to provide adequate urological services, impacting patient care. |
| High costs associated with advanced urological treatments. | Male Urology | Patients may delay seeking treatment due to financial constraints, impacting overall market growth. |
| Inconsistent quality of care across different healthcare facilities. | Male Urology | Variations in service quality can deter patients from seeking necessary treatments, affecting market demand. |
| Shortage of trained urological specialists in certain regions. | Pediatric Urology | This shortage limits the availability of care for children with urological disorders, leading to unmet healthcare needs. |
| Regulatory hurdles for new urological medical devices. | Surgery | These hurdles can delay the introduction of new treatment options, affecting patient access to care. |
China Urology Disorders Market Challenges
In China, 25% of women aged 20-50 experience urinary incontinence, creating a pressing demand for effective treatments among healthcare providers. Competition among hospitals is intensifying as over 1,000 pediatric hospitals strive to attract patients with specialised urology services, often resulting in increased marketing costs. Supply challenges arise from the growing need for urological surgical equipment; while over 30,000 units are installed, many facilities still face shortages, leading to longer wait times for surgeries. A shortage of skilled professionals is apparent, as the average age for prostate disorder diagnosis is 65, highlighting the urgent need for more trained specialists to care for this ageing demographic.
Trends in the China Urology Disorders Market
Buyers and suppliers in the China Urology Disorders Market are adjusting to the following trends.
- Shift towards Minimally Invasive Urological Procedures: There is a growing preference for minimally invasive techniques in urology, particularly in urban hospitals. In 2023, approximately 60% of urological surgeries were performed using minimally invasive methods, improving recovery times and patient satisfaction.
- Increase in Pediatric Urology Services: Pediatric hospitals are expanding their urology services to cater to the rising number of children with urological disorders. In 2023, the number of pediatric hospitals offering specialised urology services increased by 15%.
- Focus on Geriatric Urology: Healthcare providers are increasingly prioritising geriatric urology as the elderly population grows. The 'Elderly Health Care Strategy' updated in 2023 includes specific provisions for urological health services.
- Adoption of Advanced Medical Technologies: Healthcare facilities are adopting advanced medical technologies to improve treatment outcomes in urology. In 2023, over 30,000 units of urological surgical equipment were reported in use across China.
Investment Opportunities in the China Urology Disorders Market
Below are the investment opportunities with the strongest case in the China Urology Disorders Market.
- Pediatric Hospitals Expanding Services: Pediatric hospitals are actively seeking to improve their urological services to meet rising patient needs. With over 1,000 pediatric hospitals in China, investing in specialised training and equipment can yield substantial returns.
- Investment in Advanced Medical Technologies: There is a pressing need for advanced medical technologies in urology, particularly in urban healthcare facilities. Collaborating with local partners can facilitate entry into this growing market segment, with a potential market size of USD 1.11 billion by 2025.
- Growing Demand for Geriatric Urology Services: As the elderly population continues to rise, there is a strong demand for specialised urological care. Investing in geriatric urology services can tap into this expanding market, particularly in urban areas where the elderly population is concentrated.
- Enhancing Public Awareness Campaigns: Healthcare providers can invest in public awareness campaigns about urological health. Such initiatives can significantly increase patient engagement and drive demand for urological services, particularly in regions with high prevalence rates.
Government Initiatives in the China Urology Disorders Market
In 2021, the National Health Commission launched the 'National Urology Development Plan' aimed at improving urological care access and quality across China. This plan has led to increased funding for healthcare facilities, improving treatment standards for urology disorders. In 2022, the 'Urology Health Promotion Initiative' was established to raise awareness about urological disorders among the general public, further supporting patient care. The 'Urology Research Funding Program' approved in 2022 provides 200 million CNY for urology-related research projects, encouraging innovation in treatment methods. Additionally, the updated 'Elderly Health Care Strategy' includes provisions for improving urological health services for the aging population, reflecting the government's commitment to addressing this critical area.
In 2023, the government allocated a budget of 500 million CNY for urological health initiatives, aimed at improving treatment standards and access to care. The Ministry of Health oversees these initiatives, ensuring that funds are directed towards effective programs and research. The 'Urology Research Funding Program' approved in 2022 provides 200 million CNY for urology-related research projects, promoting advancements in treatment methods. Additionally, the updated 'Elderly Health Care Strategy' includes provisions for enhancing urological health services for the aging population, reflecting the government's commitment to addressing this critical area.
Future Insight of the China Urology Disorders Market
The Urology Disorders market in China will undergo notable transformations by 2032, primarily driven by the 'Urology Care Improvement Program' launched in 2023, which aims to elevate treatment standards across healthcare facilities. The government’s budget allocation of 500 million CNY for urological health initiatives will enhance resources available to hospitals, improving patient care. The increasing prevalence of urological disorders among the ageing population will spur advancements in medical technologies and training for healthcare providers. As the installed base of urological surgical equipment continues to grow, hospitals will be better equipped to handle the rising patient volumes.
Market Segmentation Analysis
The report offers a comprehensive study of the following market segments and their leading categories in the market.
By Disorder Type – Male Urology Dominated, Pediatric Urology Expected to Grow Fastest
According to Bhawna Singh, Assistant Manager at 6Wresearch, with a 44% revenue share in 2025, Male Urology was the largest disorder type category. Male Urology holds the largest share in the China Urology Disorders market due to the high prevalence of prostate disorders, particularly among men aged 65 and above. This demographic is crucial, as urological disorders account for 10% of all hospital admissions, indicating significant demand for related treatments. Pediatric Urology is set to record the highest CAGR in this split, 8.6% over 2026–2032. Pediatric Urology is experiencing rapid growth, driven by the urgent need for specialised treatments for children with urological issues, supported by over 1,000 pediatric hospitals across China. This focus on early intervention is likely to improve health outcomes for young patients, further propelling this segment's expansion. Suppliers should prioritise developing tailored solutions for both male and pediatric urology to capture the increasing market share.
By Age Group – Elderly (>60) Dominated, Children (0–16) Expected to Grow Fastest
Elderly (>60) held a 47% share of the China Urology Disorders Market by age group in 2025. The Elderly (>60) segment commands the largest share in the market, primarily due to the growing population of older adults in China, which reached approximately 200 million in 2022. This age group frequently faces urological complications, leading to a heightened demand for effective treatments and interventions. Over 2026–2032, Children (0–16) is expected to post the fastest growth, at a CAGR of 9.1%. Children (16) represent the fastest-growing age group, driven by the increasing need for targeted treatments for urological disorders in younger populations. The establishment of specialised facilities and programmes for children's health is essential for addressing these needs and improving outcomes. This trend indicates that suppliers must develop age-specific solutions to meet the rising demand from both elderly and pediatric patients.
By Treatment Pathway – Medication Dominated, Monitoring Expected to Grow Fastest
In 2025, Medication led the treatment pathway split with a 35% share. Medication leads the market due to its widespread use in treating various urological disorders, making it a preferred choice among healthcare providers. The reliance on pharmaceutical interventions is underscored by the need for effective management of chronic conditions prevalent in the population. Monitoring is projected to grow fastest, at a CAGR of 9.6% during 2026–2032. Monitoring is the fastest-growing treatment pathway, as ongoing assessment is crucial for effectively managing chronic urological conditions. This shift towards proactive health management reflects a broader trend in healthcare prioritising preventive measures and continuous care. Suppliers should invest in monitoring solutions to align with the increasing focus on chronic condition management in urology.
By End User – Pediatric Hospitals Dominated and Is Expected to Record the Fastest Growth
The largest end user category in 2025 was Pediatric Hospitals, with a 40% share of total revenue. Pediatric Hospitals dominate the market share as they are specifically equipped to address urological disorders in children, making them essential for effective treatment. The growing number of these facilities across China highlights the importance of specialised care in improving health outcomes for young patients. Pediatric Hospitals are also forecast to expand faster than any other category, at a CAGR of 9.7% over 2026–2032. Pediatric Hospitals also represent the fastest-growing end user segment, driven by the increasing recognition of the need for specialised care for children with urological issues. This dual role as both leader and fastest-growing segment suggests sustained investment in paediatric urology services. This indicates that suppliers should concentrate on developing products and services tailored for paediatric hospitals to capitalise on this growing market.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- China Urology Disorders Market Outlook
- Market Size of China Urology Disorders Market, 2025
- Forecast of China Urology Disorders Market, 2032
- Historical Data and Forecast of China Urology Disorders Revenues & Volume for the Period 2022 - 2032F
- China Urology Disorders Market Trend Evolution
- China Urology Disorders Market Drivers and Challenges
- China Urology Disorders Price Trends
- China Urology Disorders Porter's Five Forces
- China Urology Disorders Industry Life Cycle
- Historical Data and Forecast of China Urology Disorders Market Revenues & Volume By Disorder Type for the Period 2022 - 2032F
- Historical Data and Forecast of China Urology Disorders Market Revenues & Volume By Pediatric Urology for the Period 2022 - 2032F
- Historical Data and Forecast of China Urology Disorders Market Revenues & Volume By Geriatric Urology for the Period 2022 - 2032F
- Historical Data and Forecast of China Urology Disorders Market Revenues & Volume By Male Urology for the Period 2022 - 2032F
- Historical Data and Forecast of China Urology Disorders Market Revenues & Volume By Female Urology for the Period 2022 - 2032F
- Historical Data and Forecast of China Urology Disorders Market Revenues & Volume By Age Group for the Period 2022 - 2032F
- Historical Data and Forecast of China Urology Disorders Market Revenues & Volume By Children (0 16) for the Period 2022 - 2032F
- Historical Data and Forecast of China Urology Disorders Market Revenues & Volume By Elderly ( 60) for the Period 2022 - 2032F
- Historical Data and Forecast of China Urology Disorders Market Revenues & Volume By Adults for the Period 2022 - 2032F
- Historical Data and Forecast of China Urology Disorders Market Revenues & Volume By Women (20 50) for the Period 2022 - 2032F
- Historical Data and Forecast of China Urology Disorders Market Revenues & Volume By Treatment Pathway for the Period 2022 - 2032F
- Historical Data and Forecast of China Urology Disorders Market Revenues & Volume By Surgery, Monitoring for the Period 2022 - 2032F
- Historical Data and Forecast of China Urology Disorders Market Revenues & Volume By Medication, Catheters for the Period 2022 - 2032F
- Historical Data and Forecast of China Urology Disorders Market Revenues & Volume By Hormone, Surgery for the Period 2022 - 2032F
- Historical Data and Forecast of China Urology Disorders Market Revenues & Volume By Therapy, Physiotherapy for the Period 2022 - 2032F
- Historical Data and Forecast of China Urology Disorders Market Revenues & Volume By End User for the Period 2022 - 2032F
- Historical Data and Forecast of China Urology Disorders Market Revenues & Volume By Pediatric Hospitals for the Period 2022 - 2032F
- Historical Data and Forecast of China Urology Disorders Market Revenues & Volume By Long-Term Care Units for the Period 2022 - 2032F
- Historical Data and Forecast of China Urology Disorders Market Revenues & Volume By Men s Health Clinics for the Period 2022 - 2032F
- Historical Data and Forecast of China Urology Disorders Market Revenues & Volume By OB-GYN Clinics for the Period 2022 - 2032F
- China Urology Disorders Import Export Trade Statistics
- Market Opportunity Assessment By Disorder Type
- Market Opportunity Assessment By Age Group
- Market Opportunity Assessment By Treatment Pathway
- Market Opportunity Assessment By End User
- China Urology Disorders Top Companies Market Share
- China Urology Disorders Competitive Benchmarking By Technical and Operational Parameters
- China Urology Disorders Company Profiles
- China Urology Disorders Key Strategic Recommendations
Market Covered
This report examines the market across the segments below.
By Disorder Type
- Pediatric Urology
- Geriatric Urology
- Male Urology
- Female Urology
By Age Group
- Children (0–16)
- Elderly (>60)
- Adults
- Women (20–50)
By Treatment Pathway
- Surgery
- Monitoring
- Medication
- Catheters
- Hormone
- Therapy
- Physiotherapy
By End User
- Pediatric Hospitals
- Long-Term Care Units
- Men's Health Clinics
- OB-GYN Clinics
